Disclaimer:

Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.

Syeda

&times

Overview

What is Syeda?

Syeda (drospirenone and ethinyl estradiol tablets) provide an oral contraceptive regimen consisting of 28 film-coated tablets that contain the ingredients specified for each tablet below:

The inactive ingredients are corn starch, crospovidone (Polyplasdone XL), crosspovidone (Polyplasdone XL-10), lactose fast flo, macrogol/PEG 3350, magnesium stearate vegetable (kemilub em-f-v), polysorbate 80 (tween 80), polyvinyl alcohol-part. hydrolyzed, povidone k-30 (kollidon K-30), pregelatinized starch (sepistab ST200), talc and titanium dioxide. In addition, each active tablet contains yellow iron oxide.

Drospirenone (6R,7R,8R,9S,10R,13S,14S,15S,16S,17S)-1,3',4',6,6a,7,8,9,10,11,12,13, 14,15,15a,16-hexadecahydro-10,13-dimethylspiro-[17H-dicyclopropa-[6,7:15,16] cyclopenta[a]phenanthrene-17,2'(5H)-furan]-3,5'(2H)-dione) is a synthetic progestational compound and has a molecular weight of 366.5 and a molecular formula of CHO.

Ethinyl estradiol (19-nor-17α-pregna 1,3,5(10)-triene-20-yne-3,17-diol) is a synthetic estrogenic compound and has a molecular weight of 296.4 and a molecular formula of CHO.

The structural formulas are as follows:



What does Syeda look like?



What are the available doses of Syeda?

Syeda (drospirenone and ethinyl estradiol tablets) consists of 28 film-coated, tablets in the following order ():

What should I talk to my health care provider before I take Syeda?

Nursing mothers: Not recommended; can decrease milk production. ()

How should I use Syeda?

Syeda (drospirenone and ethinyl estradiol tablets) are indicated for use by women to prevent pregnancy.

Take one tablet by mouth at the same time every day. The failure rate may increase when pills are missed or taken incorrectly.

To achieve maximum contraceptive effectiveness, Syeda must be taken as directed, in the order directed on the blister pack. Single missed pills should be taken as soon as remembered.


What interacts with Syeda?

Sorry No Records found


What are the warnings of Syeda?

Sorry No Records found


What are the precautions of Syeda?

Sorry No Records found


What are the side effects of Syeda?

Sorry No records found


What should I look out for while using Syeda?

Do not prescribe Syeda to women who are known to have the following:

Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptives (COC) use. This risk increases with age, particularly in women over 35 years of

age,

and with the number of cigarettes smoked. For this reason, COCs should not be used by women who are over 35 years of age and smoke [see CONTRAINDICATIONS ()].


What might happen if I take too much Syeda?

There have been no reports of serious ill effects from overdose, including ingestion by children. Overdosage may cause withdrawal bleeding in females and nausea.

DRSP is a spironolactone analogue which has anti-mineralocorticoid properties. Serum concentration of potassium and sodium, and evidence of metabolic acidosis, should be monitored in cases of overdose.


How should I store and handle Syeda?

Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight container.Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight container.Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP]. Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP]. Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP]. Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP]. Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP]. Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP]. Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP]. Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP]. Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP]. Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP]. Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP]. Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP]. Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP]. Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP]. Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP]. Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP]. Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP]. Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP]. Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP]. Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP]. Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP]. Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP]. Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP]. Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP]. Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP]. Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP]. Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP]. Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP]. Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP]. Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP]. Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP]. Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP]. Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP]. Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP]. Atorvastatin calcium tablets are supplied as white, oval, biconvex film-coated tablets of atorvastatin calcium containing 10, 20, 40 and 80 mg atorvastatin.10 mg tablets Atorvastatin calcium tablets, 10 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. Bottles of 30 (NDC 60505-2578-3)Bottles of 90 (NDC 60505-2578-9) Bottles of 500 (NDC 60505-2578-5)Bottles of 1,000 (NDC 60505-2578-8)Bottles of 5,000 (NDC60505-2578-7) Blister of 100 (NDC 60505-2578-0) 20 mg tablets Atorvastatin calcium tablets, 20 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. Bottles of 30 (NDC 60505-2579-3)Bottles of 90 (NDC 60505-2579-9)Bottles of 500 (NDC 60505-2579-5)Bottles of 1,000 (NDC 60505-2579-8)Bottles of 5,000 (NDC 60505-2579-7) Blister of 100 (NDC 60505-2579-0) 40 mg tablets Atorvastatin calcium tablets, 40 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. Bottles of 30 (NDC 60505-2580-3)Bottles of 90 (NDC 60505-2580-9) Bottles of 500 (NDC 60505-2580-5) Bottles of 1,000 (NDC 60505-2580-8)Bottles of 4,000 (NDC 60505-2580-7)Blister of 100 (NDC 60505-2580-0) 80 mg tablets Atorvastatin calcium tablets, 80 mg, are available for oral administration as white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Bottles of 30 (NDC 60505-2671-3)Bottles of 90 (NDC 60505-2671-9) Bottles of 500 (NDC60505-2671-5)Bottles of 1,000 (NDC 60505-2671-8)Bottles of 2,500 (NDC 60505-2671-7)Blister of 100 (NDC 60505-2672-0) Storage Dispense in a tight container [see USP].


&times

Clinical Information

Chemical Structure

No Image found
Clinical Pharmacology

COCs lower the risk of becoming pregnant primarily by suppressing ovulation. Other possible mechanisms may include cervical mucus changes that inhibit sperm penetration and endometrial changes that reduce the likelihood of implantation.

Non-Clinical Toxicology
Do not prescribe Syeda to women who are known to have the following:

Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptives (COC) use. This risk increases with age, particularly in women over 35 years of

age,

and with the number of cigarettes smoked. For this reason, COCs should not be used by women who are over 35 years of age and smoke [see CONTRAINDICATIONS ()].

No pharmacokinetic-based drug-drug interaction studies have been conducted with SYNAREL. However, because nafarelin acetate is a peptide that is primarily degraded by peptidase and not by cytochrome P-450 enzymes, and the drug is only about 80% bound to plasma proteins at 4°C, drug interactions would not be expected to occur.

Stop drospirenone and ethinyl estradiol if an arterial or venous thrombotic (VTE) event occurs.

Based on presently available information on drospirenone and ethinyl estradiol, DRSP-containing COCs may be associated with a higher risk of venous thromboembolism (VTE) than COCs containing the progestin levonorgestrel or some other progestins. Epidemiologic studies that compared the risk of VTE reported that the risk ranged from no increase to a three-fold increase. Before initiating use of drospirenone and ethinyl estradiol in a new COC user or a woman who is switching from a contraceptive that does not contain DRSP, consider the risks and benefits of a DRSP-containing COC in light of her risk of a VTE. Known risk factors for VTE include smoking, obesity, and family history of VTE, in addition to other factors that contraindicate use of COCs [see .

A number of studies have compared the risk of VTE for users of drospirenone and ethinyl estradiol to the risk for users of other COCs, including COCs containing levonorgestrel. Those that were required or sponsored by regulatory agencies are summarized in .

*





§

In addition to these “regulatory studies,” other studies of various designs have been conducted. Overall, there are two prospective cohort studies (see ): the US post-approval safety study Ingenix [Seeger 2007], the European post-approval safety study EURAS (European Active Surveillance Study) [Dinger 2007]. An extension of the EURAS study, the Long-Term Active Surveillance Study (LASS), did not enroll additional subjects, but continued to assess VTE risk. There are three retrospective cohort studies: one study in the US funded by the FDA (see ), and two from Denmark [Lidegaard 2009, Lidegaard 2011]. There are two case-control studies: the Dutch MEGA study analysis [van Hylckama Vlieg 2009] and the German case-control study [Dinger 2010]. There are two nested case-control studies that evaluated the risk of non-fatal idiopathic VTE: the PharMetrics study [Jick 2011] and the GPRD study [Parkin 2011]. The results of all of these studies are presented in .

Risk ratios displayed on logarithmic scale; risk ratio 1 indicates an increased risk of VTE for DRSP.

*Comparator “Other COCs”, including LNG- containing COCs



#Some adjustment factors are indicated by superscript letters: a) Current heavy smoking, b) hypertension, c) obesity, d) family history, e) age, f) BMI, g) duration of use, h) VTE history, i) period of inclusion, j) calendar year, k) education, l) length of use, m) parity, n) chronic disease, o) concomitant medication, p) smoking, q) duration of exposure, r) site

(References: Ingenix [Seeger 2007], EURAS (European Active Surveillance Study) [Dinger 2007], LASS (Long-Term Active Surveillance Study) [Dinger, unpublished document on file], FDA-funded study [Sidney 2011], Danish [Lidegaard 2009], Danish re-analysis [ Lidegaard 2011], MEGA study [van Hylckama Vlieg 2009], German Case-Control study [Dinger 2010], PharMetrics [Jick 2011], GPRD study [Parkin 2011])

Although the absolute VTE rates are increased for users of hormonal contraceptives compared to non-users, the rates during pregnancy are even greater, especially during the post-partum period (see ). The risk of VTE in women using COCs has been estimated to be 3 to 9 per 10,000 woman-years. The risk of VTE is highest during the first year of use. Data from a large, prospective cohort safety study of various COCs suggest that this increased risk, as compared to that in non-COC users, is greatest during the first 6 months of COC use. Data from this safety study indicate that the greatest risk of VTE is present after initially starting a COC or restarting (following a 4 week or greater pill-free interval) the same or a different COC.

The risk of thromboembolic disease due to oral contraceptives gradually disappears after COC use is discontinued.

Figure 2

If feasible, stop drospirenone and ethinyl estradiol at least 4 weeks before and through 2 weeks after major surgery or other surgeries known to have an elevated risk of thromboembolism.

Start drospirenone and ethinyl estradiol no earlier than 4 weeks after delivery, in women who are not breastfeeding. The risk of postpartum thromboembolism decreases after the third postpartum week, whereas the risk of ovulation increases after the third postpartum week.

Use of COCs also increases the risk of arterial thromboses such as strokes and myocardial infarctions, especially in women with other risk factors for these events.

COCs have been shown to increase both the relative and attributable risks of cerebrovascular events (thrombotic and hemorrhagic strokes), although, in general, the risk is greatest among older (>35 years of age), hypertensive women who also smoke. COCs also increase the risk for stroke in women with other underlying risk factors.

Oral contraceptives must be used with caution in women with cardiovascular disease risk factors.

Stop drospirenone and ethinyl estradiol if there is unexplained loss of vision, proptosis, diplopia, papilledema, or retinal vascular lesions. Evaluate for retinal vein thrombosis immediately. [see ]

The following serious adverse reactions with the use of COCs are discussed elsewhere in the labeling:

&times

Reference

This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"

While we update our database periodically, we cannot guarantee it is always updated to the latest version.

&times

Review

Rate this treatment and share your opinion


Helpful tips to write a good review:

  1. Only share your first hand experience as a consumer or a care giver.
  2. Describe your experience in the Comments area including the benefits, side effects and how it has worked for you. Do not provide personal information like email addresses or telephone numbers.
  3. Fill in the optional information to help other users benefit from your review.

Reason for Taking This Treatment

(required)

Click the stars to rate this treatment

This medication has worked for me.




This medication has been easy for me to use.




Overall, I have been satisfied with my experience.




Write a brief description of your experience with this treatment:

2000 characters remaining

Optional Information

Help others benefit from your review by filling in the information below.
I am a:
Gender:
&times

Professional

Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72
&times

Tips

Tips

&times

Interactions

Interactions

A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).